SIGA Technologies Inc
I dumped my SIGA nasty wins on this. I have other nasty wins too but this one I made sure to give back to any bag holders if need be. Come tonight and Tm, I'll sacrifice another nasty win...End of the day I made those by button pressing. Ps: I'm not saying nasty wins like my great grandkids will never starve, but nasty as in I couldn't even eat if it wasn't for WSB and those wins that generated more wins to come.
SIGA technologies and Revlon. SIGA already has government contracts for their monkeypox treatment and have been reaching all-time highs, which could lead to more and more gamma in the options chain. REV didn’t take the buyout offer from the biggest/wealthiest company in India, which tells me there’s something going on behind the scenes. Also, they’ve been shorted and has had reverse splits to the point where the float is so low, it could end up volatile.
I feel like this recently happened with SIGA. The fda released a statement saying their medication didn’t work essentially, prices plummeted. New come out the US government bought 30millions worth. Went right back up to where it was at.
Nice! Glad to hear that. She's up 180% so far, and I think she still has room for more. HOWEVER, be careful. It's not going to be a rosy staircase straight up. She'll be like SIGA. So consider peeling some profits along the way, then maybe jump back in after a consolidation/pullback, rinse and repeat. I mean, look at her float. If a big retail trader feels jumpy and sells, she's bound to take a big hit. So be mindful of that.
🐒🐒🐒monkeypoxbro🐒🐒🐒 ​ Admin banned again (they literally linked a simpson's quote lol \[well to be pedantic, they linked a 'removed by reddit' commen that I had to use uneddit to find out was a simpson's quote because they don't actually tell you why they ban you, just 'you're banned for 7 days here's a random empty comment as our rationale lol fuck you'\]) and if this is similar to last time this account will be admin shadowbanned after this comment but: ​ SGIA just does this ¯\\\\\\\_(ツ)\_/¯ Take profits to cover cost basis when you can, don't fomo/chase, enjoy the ride. ​ Monkeypox has been interesting, my sister (the nurse-in-training one, yes I have more than 1 sister) actually had a monkeypox case in her hospital and the dude's apparently not looking good, it's erupting pox in his throat and possibly lungs, causing breathing problems (enough so that he's on a vent) and all. Which, if you recall, is one of the major bioweapon theories - if they get it in the respiratory tract due to either direct contact with the pox or lesion formation due to pneumonia or other respiratory disease (cough *covid* cough) they could start forming pox at those sites which will really fuck shit up. Keep an eye out for that. [https://www.researchgate.net/publication/13205541\_Cutaneous\_Manifestations\_of\_Biological\_Warfare\_and\_Related\_Threat\_Agents](https://www.researchgate.net/publication/13205541_Cutaneous_Manifestations_of_Biological_Warfare_and_Related_Threat_Agents) ​ As predicted, the 'Dog got monkeypox' narrative is flying around, has opened the conversation to human-zoonotic-human transmission in the media (always a real risk, recall the normal carriers of the OG disease are rodents/prariedogs/monkeys, so zoonotic transmission is expected) but they don't seem to have really ramped up the fear porn on that yet - give it a week. ​ Another bit of media/fear narrative interest - you see the dude with the Aids+monkeypox nose? Nasty. Look forward to more of that, a huge portion of the currently infected population has HIV/AIDS. Other interactions will likely be seen, we're 'only' at 45k or so cases so far. ​ Good news for SIGA - rumors of more tecnomvirant (TPOXX) orders from govts. ​ The vaccine stretching methods seem to be a mixed bag - for one, intradermal injections definitely do work (if properly administered and we can extrapolate reliably from existing intradermal efficacy data for other shots). Bad news is it seems many states and countries are cancelling the 2nd dose appointment for those receiving the first dose 'in interest of stretching supply as much as possible' and they claim it won't negatively impact efficacy - which the data *dosen't* support (only 1/5 or so show target immune response to the first dose, hence the requirement for the second 28 days later). So we'll see what happens there. Again, hopefully we don't have to dip into the ACAM2000 doses because there's no way that ends well (again, don't even think about getting this if you have eczema, look up the interaction with ACAM2000 if you want but prepared to see huge patches of necrosis). ​ Testing wise, don't be fooled by the UK plateau - recall that their testing capacity is still extremely limited, this is likely a similar situation to New York early on where they've just been maxing out their test capacity and therefore 'plateaued confirmed case growth' - technically true, but only because they cannot test enough. ​ Also, there was some stuff here about the NTI paper over the weekend - definitely could be coincidence, but the timing is very sus especially with all the mutations in the genome of the circulating virus (recall: [https://www.cidrap.umn.edu/news-perspective/2022/06/virus-causing-monkeypox-outbreak-has-mutated-spread-easier](https://www.cidrap.umn.edu/news-perspective/2022/06/virus-causing-monkeypox-outbreak-has-mutated-spread-easier)) - we're still not 'officially' certain what these mutations have done to the virus itself, but it *is* spreading easier and faster outside of regions where it normally spreads, so it *is* behaving differently. Don't be fooled into thinking it's 'just the normal monkeypox' - the fact that it's spreading outside of Africa should be proof enough that it's not. There's also this: [https://www.sciencedirect.com/science/article/pii/S1995820X22000414](https://www.sciencedirect.com/science/article/pii/S1995820X22000414) \- note the lab, note the virus they're playing with. Not going further than that with this because there's not enough data to make conclusions (either way) but it's at least suspicious and warranting more detailed investigation. Unfortunately, I haven't been able to find any further info on either side, so for now it stays there. BUUUT keep an eye out because though coincidence+correlation doesn't necessitate causality, it does wiggle its eyebrows suggestively and say 'look over here'
I'm up quite a bid on SIGA and holding because I believe that shorts are going to close soon *and* they are just a profitable company with a product that is a de facto monopoly. Can't believe that I'm in on 2 meme stocks now lol.
From 8/2 to 8/15 SIGA went from $17.57 to a high of $26.99 closing at $26.15. It made new ATH 5 times during that period and has made continuous ATH the last three days, during this time the average Short volume ratio has been 54.7%, with a SI of 14% from fintel this is turning into a major squeeze play as almost ALL shorts are under water right now, and continues to be more and more underwater as the price just seems to keep pumping.
I have positions in GME, BBBY, SIGA and now GEO. I don’t have a position in FUBO but I am thinking of opening one because Ryan Reynolds struck a deal with them and I have been googling information, seems they are adding new executives and I believe will try and compete with Netflix with entertainment AND sports 🤷♀️
Its up ~400% in a month but I agree at current price Tpoxx in every wallgreens is definitely not priced in. Especially given the US vxn hesitancy I think theres a ton of market potential here. Watching case numbers real close next few weeks and if theres no plateau will almost certainly close some other positions to go further into SIGA.
I’m surprised SIGA isn’t getting more attention from either apes or Wall Street in general. I guess we’ll just be able to continue to quietly build our positions while case counts continue to rise. Once the EUA and/or EU/UK orders come in, this tiny float should rip. I haven’t seen anything regarding the WHO on TPOXX. A little jawboning from them would go a long way too.
SIGA has potential to squeeze, out of the last two weeks the average short sell volume has been ~50% and it has continued to make new ATH and with an POTENTIAL FDA approval for TPOXX this could get ugly for the shorts real quick. 15% SI I believe
Look man, you can always turn shit around. Personally, I went from 125k to 0 in two years. Basically I was young and dumb and had inherited some money. Well I hit the books a little, watched some investment videos on YouTube, and started saving money. After a little while I had 5k saved up. Well inside a year I turned that 5k into a 100k. I just invested conservatively and when I saw some great opportunities I did a yolo (COVID/AMC "squeeze"). You just need to play it safe and WAIT for the right opportunity to jump in. And that opportunity may take years to come around, but they always show up in one form or another. Could be another pandemic (monkey pox/$SIGA), oil crisis (probably this winter if Russia goes bananas), another squeeze (BBBY), etc. Just wait it out, play it safe in the meantime, and stay the hell away from options.
SIGA Technologies. They already have a government contract for their monkeypox treatment TPOXX and they keep reaching all-time highs. Option chain is getting loaded and the market cap of $1.5B can get way higher if monkeypox gets worse.
I wish I could comment something insightful but I have no idea about NVAX. I believe monkeypox will be the next pandemic, sound outlandish but it's going to happen. I highly recommend getting into SIGA but first wait for the price to plummet when they reveal the treatment is ineffective. I'm planning to liqaute my position weeks prior to the announcement and load puts. Then, I will re-buy all my shares and more with the money I made at a lower share price and then really go to the moon. Mark these words.
HKD wasnt even available to retail and no one here touched it when it was happening and called it out for the chinese money laundering it was. Secondly SIGA is doing just fine and making plenty of us money. No one is under any illusions this is a long term play.
This is false. Monkeypox is actually an instrument of divine rapture, as I wrote about here: [https://www.reddit.com/r/wallstreetbets/comments/wgepdx/transcendental\_trading\_55\_in\_1\_day\_utilizing/](https://www.reddit.com/r/wallstreetbets/comments/wgepdx/transcendental_trading_55_in_1_day_utilizing/) ​ SIGA itself is located at **666** THIRD AVENUE, NEW YORK, NY 10017. Now, why do you think that is, Martin?
To be a little contrarian, I'll talk about two stocks that break some of the requirements I just mentioned. $F and $SIGA. $F has a ton of debt. $85 billion in Q2 2022. Ford Motor Credit is a factor in this that can't be ignored, but even then that's an incredible amount. That said, they've been successfully reducing their debt 15% YoY like clockwork and the leadership seems committed to reducing debt and increasing cashflow. But what really sells this stock for me is their move into EVs. The F-150 Lightning is a killer product. I have truck friends who would never consider an EV at all who are salivating over it. Reviews are glowing. If this is their first entry into EVs, taking the most beloved, best-selling vehicle in their inventory and converting it to electric, that to me shows that they're committed to competing with TSLA by not competing with TSLA, if that makes sense. I got in around $14 and I have a price target of $20 and because the stock doesn't really move very quickly, it's a long hold so I don't mind picking up some dividends along the way. $SIGA is riskier. It's already a P/E of almost $27. But here's where they also have a fantastic product. Patients and doctors have been swearing by TPOXX as a miracle drug. Studies have shown hardly any adverse effects and zero serious adverse effects. Unlike the JYNNEOS vaccine, production can ramp up with demand. And demand is skyrocketing. I'm not a doomer, Monkeypox isn't going to be anything like the tsunami of COVID, but it will be a serious issue, it will start spreading outside of the gay male demographic (already has) and will be a slow, consistent grind of cluster outbreaks within social circles like families, daycares and preschools and sexual networks. So the P/E doesn't bother me as much here because it has room to grow and given the positive data coming in, an Emergency Use Authorization is on the horizon. Plus, the company has like $130m cash on hand, tons of assets and very little debt. A course costs $300 for the US and $900-$1200 for other countries. It's shelf stable and has a long expiration date. Foreign countries are going to want to stock up. I got in at $17 and my price target was originally $30 in the next 9 months. We're already over $24 though, so who knows where it goes from there. If it gets over $30 I'll set a stop limit and forget about it. I try to keep my price targets relatively conservative. Hope that helps!
I bought SIGA at 6.77 and sold it at 14 dollars, then sold puts and bought them back too. Right now, the stock is ridiculous. When I went to pose the DD on WSB, a mod banned it because "SIGA has insufficient market capital" ; guess it doesn't now....